(Q41298001)

29 September 2017

title

Monocytes and impaired leukocyte migration inhibitory factor production in head and neck squamous carcinoma (English)

1 reference

29 September 2017

Beauchamp ML

1

1 reference

29 September 2017

Wolf GT

series ordinal

2

1 reference

29 September 2017

language of work or name

1 reference

1 January 1988

1 reference

29 September 2017

1 reference

29 September 2017

volume

10

1 reference

29 September 2017

issue

3

1 reference

29 September 2017

page(s)

187-194

1 reference

The ability of macrophages from head and neck cancer patients to kill tumor cells. Effect of prostaglandin inhibitors on cytotoxicity

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Mononuclear phagocyte function in head and neck cancer: depression of murine macrophage accumulation by low molecular weight factors derived from head and neck carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Mononuclear phagocyte function in head and neck cancer. Chemotactic responsiveness of blood monocytes in correlation between histologic grade of the tumor and infiltration of these cells into the tumor area

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Lymphokine Production and Lymphocyte Subpopulations in Patients With Head and Neck Squamous Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Effect of phytohaemagglutinin in the leucocyte migration inhibition test as a measure of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Cytochemical Identification of Monocytes and Granulocytes

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Evaluation of blocking mechanisms against immunological responses in patients with laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

The effect of indomethacin on the growth of epidermoid carcinoma of the palate in rats

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis Inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Production of leukocyte inhibitory factor (LIF) in Hodgkin's disease. Spontaneous production of an inhbiitor of normal lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Monocyte-mediated suppression of T lymphocyte proliferative response in breast and colorectal cancer patients: specific action of levamisole on suppressor monocytes

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100307

7 January 2021

Identifiers

DOI

10.1002/HED.2890100307

1 reference

29 September 2017

1 reference